why choose us

First received: October 18, 2023

Clinical Trial: A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Plaque Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Brief Summary: The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.

Read more